Visterra Inc.
Emily Michael, Ph.D., is a Senior Scientist in Preclinical Development at Visterra Inc. since April 2022. Previously, Emily served as a Senior Scientist at Oasis Pharmaceuticals from May 2019 to April 2022, supporting the research and development of preclinical programs related to NASH and Atopic Dermatitis, and contributing to regulatory submissions. Emily's academic background includes a Ph.D. in Biochemistry from Tufts University School of Medicine (2012-2017), where research focused on GPCR signaling and inflammation in metabolic diseases. Prior research experience includes roles as Research Assistant II at Tufts Medical Center and Research Technician at Boston University, with a strong emphasis on cellular and molecular techniques. Emily earned a Bachelor's Degree in Biology with a Specialization in Neuroscience from Boston University (2005-2009).
Visterra Inc.
1 followers
Visterra, Inc. engages in pharmaceutical drug research and development of therapeutic and diagnostic products for infectious diseases. It also provides structure-based design of therapeutics and diagnostic platforms, based on an understanding of glycobiology and glycochemistry. The company was formerly known as Parasol Therapeutics, Inc. andchanged its name in May 2010. Visterra, Inc. was founded in 2007 and is based in Cambridge, Massachusetts.